An experimental study of the sensorized strain wave gear RT1-T and its capabilities for torque control in robotic joints von Schuller, Robert, Reinecke, Jens, Maurenbrecher, Henry, Ott, Christian, Albu-Schaeffer, Alin, Deutschmann, Bastian, Buettner, Fred, Heim, Jens, Benkert, Frank, Glueck, Stefan

Volltext

Molecularly targeted therapies for metastatic triple-negative breast cancer von Bayraktar, Soley, Glück, Stefan

Volltext

nab -Paclitaxel for the Treatment of Aggressive Metastatic Breast Cancer von Glück, Stefan

Volltext

Extending the Clinical Benefit of Endocrine Therapy for Women With Hormone Receptor–Positive Metastatic Breast Cancer: Differentiating Mechanisms of Action von Glück, Stefan

Volltext

Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy von Glück, Stefan, de Snoo, Femke, Peeters, Justine, Stork-Sloots, Lisette, Somlo, George

Volltext

Long‐term psychological benefits of cognitive‐behavioral stress management for women with breast cancer: 11‐year follow‐up of a randomized controlled trial von Stagl, Jamie M., Bouchard, Laura C., Lechner, Suzanne C., Blomberg, Bonnie B., Gudenkauf, Lisa M., Jutagir, Devika R., Glück, Stefan, Derhagopian, Robert P., Carver, Charles S., Antoni, Michael H.

Volltext

Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival comp... von Koru-Sengul, Tulay, Santander, Ana M., Miao, Feng, Sanchez, Lidia G., Jorda, Merce, Glück, Stefan, Ince, Tan A., Nadji, Mehrad, Chen, Zhibin, Penichet, Manuel L, Cleary, Margot P., Torroella-Kouri, Marta

Volltext

TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab von Glück, Stefan, Ross, Jeffrey S., Royce, Melanie, McKenna, Edward F., Perou, Charles M., Avisar, Eli, Wu, Lin

Volltext

Systemic therapy options in BRCA mutation-associated breast cancer von Bayraktar, Soley, Glück, Stefan

Volltext

A cost-benefit analysis of bevacizumab in combination with paclitaxel in the first-line treatment of patients with metastatic breast cancer von Montero, Alberto J., Avancha, Kiran, Glück, Stefan, Lopes, Gilberto

Volltext

A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up von Stagl, Jamie M., Lechner, Suzanne C., Carver, Charles S., Bouchard, Laura C., Gudenkauf, Lisa M., Jutagir, Devika R., Diaz, Alain, Yu, Qilu, Blomberg, Bonnie B., Ironson, Gail, Glück, Stefan, Antoni, Michael H.

Volltext

Treating breast cancer in the 21st century: emerging biological therapies von Tinoco, Gabriel, Warsch, Sean, Glück, Stefan, Avancha, Kiran, Montero, Alberto J

Volltext

Brief Cognitive-Behavioral and Relaxation Training Interventions for Breast Cancer: A Randomized Controlled Trial von Gudenkauf, Lisa M., Antoni, Michael H., Stagl, Jamie M., Lechner, Suzanne C., Jutagir, Devika R., Bouchard, Laura C., Blomberg, Bonnie B., Glück, Stefan, Derhagopian, Robert P., Giron, Gladys L., Avisar, Eli, Torres-Salichs, Manuel A., Carver, Charles S.

Volltext

Exemestane as first-line therapy in postmenopausal women with recurrent or metastatic breast cancer von Glück, Stefan

Volltext

Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer von Jackisch, Christian, Barcenas, Carlos H., Bartsch, Rupert, Palma, Jack Di, Glück, Stefan, Harbeck, Nadia, Macedo, Guilherme, O'Shaughnessy, Joyce, Pistilli, Barbara, Ruiz-Borrego, Manuel, Rugo, Hope S.

Volltext

Phase 2 study of eribulin mesylate as first-line therapy for locally recurrent or metastatic human epidermal growth factor receptor 2-negative breast cancer von McIntyre, Kristi, O’Shaughnessy, Joyce, Schwartzberg, Lee, Glück, Stefan, Berrak, Erhan, Song, James X., Cox, David, Vahdat, Linda T.

Volltext

A cost effectiveness study of eribulin versus standard single-agent cytotoxic chemotherapy for women with previously treated metastatic breast cancer von Lopes, Gilberto, Glück, Stefan, Avancha, Kiran, Montero, Alberto J.

Volltext

Eribulin mesylate, a novel microtubule inhibitor in the treatment of breast cancer von Cortes, Javier, Montero, Alberto J, Glück, Stefan

Volltext

Can mammographic and sonographic imaging features predict the Oncotype DX™ recurrence score in T1 and T2, hormone receptor positive, HER2 negative and axillary lymph node negative... von Yepes, Monica Maria, Romilly, Ada Pat, Collado-Mesa, Fernando, Net, Jose Miguel, Kiszonas, Richard, Arheart, Kristopher L., Young, Daniel, Glück, Stefan

Volltext

Introduction to special issue Translational goals of neoadjuvant therapy von Gluck, Stefan

Volltext